Welling P G, Baumueller A, Lau C C, Madsen P O
Antimicrob Agents Chemother. 1977 Sep;12(3):328-34. doi: 10.1128/AAC.12.3.328.
The pharmacokinetics of the new aminoglycoside antibiotic netilmicin were examined after single intravenous injections at two different dose levels to elderly male patients. The durg obeyed two-compartment model kinetics in serum, and elimination was monoexponential from 1 to 2 h after dosing. Netilmicin levels in serum were above minimum inhibitory concentration values for most susceptible organisms for up to 8 h after dosing in normal individuals and for at least 12 h in uremic patients. Urine levels of netilmicin were uniformly above minimum inhibitory concentration values throughout 24 h after dosing. Netilmicin distribution characteristics were largely independent of both dose level and renal function. Netilmicin elimination kinetics were independent of dose level but were markedly influenced by renal function. Relationships are described between netilmicin elimination and renal function indicators, which provide a basis for dosage adjustment in individuals with renal function impairment.
对老年男性患者在两个不同剂量水平单次静脉注射新氨基糖苷类抗生素奈替米星后,对其药代动力学进行了研究。该药物在血清中符合二室模型动力学,给药后1至2小时消除呈单指数形式。在正常个体中,给药后长达8小时血清中奈替米星水平高于大多数易感微生物的最低抑菌浓度值,在尿毒症患者中至少12小时高于该值。给药后24小时内,奈替米星的尿液水平始终高于最低抑菌浓度值。奈替米星的分布特征在很大程度上与剂量水平和肾功能无关。奈替米星的消除动力学与剂量水平无关,但受肾功能显著影响。描述了奈替米星消除与肾功能指标之间的关系,这为肾功能受损个体的剂量调整提供了依据。